Celon’s business operations are clearly focused on:
  • Branded Formulations
  • Generics
  • Through its three business verticals, Celon offers a portfolio of products including innovative formulations.
  • Therapeutic focus is on Cancer Care (Oncology), Critical Care (Cardiology/Anesthesia/Anti infectives).
  • Target markets for branded generics business are India and ROW markets such as Asia-Pacific, CIS, Africa, Latin America & MENA.
  • Target markets for unbranded generics business are regulated markets such as US, EU, Australia and Brazil.